Chronic Fatigue Syndrome Trial, Recruiting NCT07352254 Sponsor: Hannover Medical School Condition: Chronic Fatigue Syndrome
Back to Chronic Fatigue Syndrome

Chronic Fatigue Syndrome Trial, Recruiting

NCT07352254
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) based on a specific set of medical standards called the Canadian Consensus Criteria
  • Your overall ability to function day-to-day is significantly limited, as measured by a specialist scoring tool called the Bell Score (a score of 30 or below, where lower scores mean greater limitations)
  • After physical or mental activity, your symptoms get worse and this worsening lasts more than 14 hours
  • You are between 19 and 69 years old

Who may not be able to join:

  • You have a pre-existing condition or other health problem that has already caused, or could have caused, limitations in your ability to move around or think clearly — for example, certain diseases affecting the brain or nervous system (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Meike Dirks, MD, Hannover Medical School

Phone: +495115323145

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hannover Medical School
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
1 October 2028

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Short Form (SF)-36 health survey, physical score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov